Search hospitals > California > Riverside
Kaiser Permanente-Riverside
Claim this profileRiverside, California 92505
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
143 reported clinical trials
8 medical researchers
Summary
Kaiser Permanente-Riverside is a medical facility located in Riverside, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser Permanente-Riverside is involved with conducting 143 clinical trials across 344 conditions. There are 8 research doctors associated with this hospital, such as Gary L. Buchschacher, Helen H. Moon, Eric C. McGary, and Ashraf R. Aziz.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Gary L. BuchschacherKaiser Permanente-Anaheim6 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
12 reported clinical trials
33 drugs studied
Helen H. MoonKaiser Permanente-Riverside7 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
13 reported clinical trials
23 drugs studied
Eric C. McGaryKaiser Permanente-Anaheim9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
18 drugs studied
Ashraf R. AzizKaiser Permanente-Baldwin Park5 years of reported clinical research
Studies Lymphoma
Studies Leukemia
11 reported clinical trials
31 drugs studied
Clinical Trials running at Kaiser Permanente-Riverside
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Cancer
Lymphoma
Colorectal Cancer
Small Intestinal Adenocarcinoma
Anal Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-Riverside?
Kaiser Permanente-Riverside is a medical facility located in Riverside, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Kaiser Permanente-Riverside is involved with conducting 143 clinical trials across 344 conditions. There are 8 research doctors associated with this hospital, such as Gary L. Buchschacher, Helen H. Moon, Eric C. McGary, and Ashraf R. Aziz.